nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—migraine—Prednisone—ankylosing spondylitis	0.287	0.341	CpDpCtD
Cyclobenzaprine—osteoarthritis—Methylprednisolone—ankylosing spondylitis	0.278	0.33	CpDpCtD
Cyclobenzaprine—osteoarthritis—Prednisone—ankylosing spondylitis	0.278	0.33	CpDpCtD
Cyclobenzaprine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0198	0.216	CbGbCtD
Cyclobenzaprine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.015	0.164	CbGbCtD
Cyclobenzaprine—CYP3A4—Betamethasone—ankylosing spondylitis	0.0128	0.141	CbGbCtD
Cyclobenzaprine—CYP3A4—Prednisolone—ankylosing spondylitis	0.0127	0.139	CbGbCtD
Cyclobenzaprine—CYP3A4—Prednisone—ankylosing spondylitis	0.012	0.131	CbGbCtD
Cyclobenzaprine—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0117	0.129	CbGbCtD
Cyclobenzaprine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00747	0.0817	CbGbCtD
Cyclobenzaprine—Angioedema—Triamcinolone—ankylosing spondylitis	0.000176	0.00268	CcSEcCtD
Cyclobenzaprine—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000176	0.00267	CcSEcCtD
Cyclobenzaprine—Hallucination—Prednisone—ankylosing spondylitis	0.000174	0.00265	CcSEcCtD
Cyclobenzaprine—Malaise—Triamcinolone—ankylosing spondylitis	0.000174	0.00264	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Methotrexate—ankylosing spondylitis	0.000173	0.00264	CcSEcCtD
Cyclobenzaprine—Malaise—Methylprednisolone—ankylosing spondylitis	0.000173	0.00264	CcSEcCtD
Cyclobenzaprine—Vertigo—Triamcinolone—ankylosing spondylitis	0.000173	0.00263	CcSEcCtD
Cyclobenzaprine—Syncope—Triamcinolone—ankylosing spondylitis	0.000173	0.00263	CcSEcCtD
Cyclobenzaprine—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000173	0.00263	CcSEcCtD
Cyclobenzaprine—Syncope—Methylprednisolone—ankylosing spondylitis	0.000172	0.00262	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000171	0.0026	CcSEcCtD
Cyclobenzaprine—Oedema—Prednisolone—ankylosing spondylitis	0.000171	0.0026	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.00017	0.00258	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000169	0.00257	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000169	0.00257	CcSEcCtD
Cyclobenzaprine—Shock—Prednisolone—ankylosing spondylitis	0.000168	0.00256	CcSEcCtD
Cyclobenzaprine—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.000168	0.00256	CcSEcCtD
Cyclobenzaprine—Convulsion—Triamcinolone—ankylosing spondylitis	0.000167	0.00254	CcSEcCtD
Cyclobenzaprine—Tachycardia—Prednisolone—ankylosing spondylitis	0.000167	0.00254	CcSEcCtD
Cyclobenzaprine—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000167	0.00253	CcSEcCtD
Cyclobenzaprine—Hypertension—Triamcinolone—ankylosing spondylitis	0.000166	0.00253	CcSEcCtD
Cyclobenzaprine—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000166	0.00252	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000165	0.00251	CcSEcCtD
Cyclobenzaprine—Myalgia—Triamcinolone—ankylosing spondylitis	0.000164	0.00249	CcSEcCtD
Cyclobenzaprine—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000164	0.00249	CcSEcCtD
Cyclobenzaprine—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000163	0.00248	CcSEcCtD
Cyclobenzaprine—Drowsiness—Methotrexate—ankylosing spondylitis	0.000163	0.00248	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000162	0.00247	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000162	0.00247	CcSEcCtD
Cyclobenzaprine—Discomfort—Triamcinolone—ankylosing spondylitis	0.000162	0.00246	CcSEcCtD
Cyclobenzaprine—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000162	0.00246	CcSEcCtD
Cyclobenzaprine—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00016	0.00244	CcSEcCtD
Cyclobenzaprine—Angioedema—Betamethasone—ankylosing spondylitis	0.00016	0.00243	CcSEcCtD
Cyclobenzaprine—Angioedema—Dexamethasone—ankylosing spondylitis	0.00016	0.00243	CcSEcCtD
Cyclobenzaprine—Stomatitis—Methotrexate—ankylosing spondylitis	0.000159	0.00241	CcSEcCtD
Cyclobenzaprine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000158	0.00241	CcSEcCtD
Cyclobenzaprine—Malaise—Betamethasone—ankylosing spondylitis	0.000158	0.0024	CcSEcCtD
Cyclobenzaprine—Malaise—Dexamethasone—ankylosing spondylitis	0.000158	0.0024	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000157	0.00239	CcSEcCtD
Cyclobenzaprine—Oedema—Triamcinolone—ankylosing spondylitis	0.000157	0.00239	CcSEcCtD
Cyclobenzaprine—Vertigo—Betamethasone—ankylosing spondylitis	0.000157	0.00239	CcSEcCtD
Cyclobenzaprine—Vertigo—Dexamethasone—ankylosing spondylitis	0.000157	0.00239	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000157	0.00239	CcSEcCtD
Cyclobenzaprine—Syncope—Betamethasone—ankylosing spondylitis	0.000157	0.00238	CcSEcCtD
Cyclobenzaprine—Syncope—Dexamethasone—ankylosing spondylitis	0.000157	0.00238	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Prednisone—ankylosing spondylitis	0.000156	0.00238	CcSEcCtD
Cyclobenzaprine—Sweating—Methotrexate—ankylosing spondylitis	0.000156	0.00237	CcSEcCtD
Cyclobenzaprine—Shock—Triamcinolone—ankylosing spondylitis	0.000155	0.00235	CcSEcCtD
Cyclobenzaprine—Insomnia—Prednisolone—ankylosing spondylitis	0.000155	0.00235	CcSEcCtD
Cyclobenzaprine—Alopecia—Prednisone—ankylosing spondylitis	0.000155	0.00235	CcSEcCtD
Cyclobenzaprine—Shock—Methylprednisolone—ankylosing spondylitis	0.000154	0.00235	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000154	0.00234	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000154	0.00234	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000154	0.00233	CcSEcCtD
Cyclobenzaprine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000154	0.00233	CcSEcCtD
Cyclobenzaprine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000153	0.00233	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000152	0.00231	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000152	0.00231	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000152	0.00231	CcSEcCtD
Cyclobenzaprine—Convulsion—Dexamethasone—ankylosing spondylitis	0.000152	0.0023	CcSEcCtD
Cyclobenzaprine—Convulsion—Betamethasone—ankylosing spondylitis	0.000152	0.0023	CcSEcCtD
Cyclobenzaprine—Hypertension—Betamethasone—ankylosing spondylitis	0.000151	0.00229	CcSEcCtD
Cyclobenzaprine—Hypertension—Dexamethasone—ankylosing spondylitis	0.000151	0.00229	CcSEcCtD
Cyclobenzaprine—Myalgia—Dexamethasone—ankylosing spondylitis	0.000149	0.00226	CcSEcCtD
Cyclobenzaprine—Myalgia—Betamethasone—ankylosing spondylitis	0.000149	0.00226	CcSEcCtD
Cyclobenzaprine—Anxiety—Betamethasone—ankylosing spondylitis	0.000148	0.00226	CcSEcCtD
Cyclobenzaprine—Anxiety—Dexamethasone—ankylosing spondylitis	0.000148	0.00226	CcSEcCtD
Cyclobenzaprine—Discomfort—Dexamethasone—ankylosing spondylitis	0.000147	0.00224	CcSEcCtD
Cyclobenzaprine—Discomfort—Betamethasone—ankylosing spondylitis	0.000147	0.00224	CcSEcCtD
Cyclobenzaprine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000147	0.00223	CcSEcCtD
Cyclobenzaprine—Hepatitis—Methotrexate—ankylosing spondylitis	0.000146	0.00222	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000145	0.00221	CcSEcCtD
Cyclobenzaprine—Vision blurred—Prednisone—ankylosing spondylitis	0.000144	0.00218	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000143	0.00218	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000143	0.00217	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000143	0.00217	CcSEcCtD
Cyclobenzaprine—Oedema—Dexamethasone—ankylosing spondylitis	0.000143	0.00217	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000143	0.00217	CcSEcCtD
Cyclobenzaprine—Oedema—Betamethasone—ankylosing spondylitis	0.000143	0.00217	CcSEcCtD
Cyclobenzaprine—Insomnia—Triamcinolone—ankylosing spondylitis	0.000142	0.00216	CcSEcCtD
Cyclobenzaprine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000142	0.00216	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000141	0.00215	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000141	0.00215	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000141	0.00214	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000141	0.00214	CcSEcCtD
Cyclobenzaprine—Shock—Betamethasone—ankylosing spondylitis	0.00014	0.00213	CcSEcCtD
Cyclobenzaprine—Shock—Dexamethasone—ankylosing spondylitis	0.00014	0.00213	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00014	0.00213	CcSEcCtD
Cyclobenzaprine—Agitation—Prednisone—ankylosing spondylitis	0.00014	0.00213	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00014	0.00212	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00014	0.00212	CcSEcCtD
Cyclobenzaprine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000139	0.00212	CcSEcCtD
Cyclobenzaprine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000139	0.00212	CcSEcCtD
Cyclobenzaprine—Angioedema—Prednisone—ankylosing spondylitis	0.000139	0.00212	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000138	0.0021	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000138	0.0021	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000138	0.0021	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000138	0.0021	CcSEcCtD
Cyclobenzaprine—Malaise—Prednisone—ankylosing spondylitis	0.000137	0.00209	CcSEcCtD
Cyclobenzaprine—Vertigo—Prednisone—ankylosing spondylitis	0.000137	0.00208	CcSEcCtD
Cyclobenzaprine—Syncope—Prednisone—ankylosing spondylitis	0.000137	0.00208	CcSEcCtD
Cyclobenzaprine—Tinnitus—Methotrexate—ankylosing spondylitis	0.000136	0.00207	CcSEcCtD
Cyclobenzaprine—Anorexia—Betamethasone—ankylosing spondylitis	0.000136	0.00207	CcSEcCtD
Cyclobenzaprine—Anorexia—Dexamethasone—ankylosing spondylitis	0.000136	0.00207	CcSEcCtD
Cyclobenzaprine—Urticaria—Prednisolone—ankylosing spondylitis	0.000136	0.00207	CcSEcCtD
Cyclobenzaprine—Fatigue—Triamcinolone—ankylosing spondylitis	0.000136	0.00206	CcSEcCtD
Cyclobenzaprine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000135	0.00206	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000134	0.00203	CcSEcCtD
Cyclobenzaprine—Hypotension—Betamethasone—ankylosing spondylitis	0.000133	0.00203	CcSEcCtD
Cyclobenzaprine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000133	0.00203	CcSEcCtD
Cyclobenzaprine—Convulsion—Prednisone—ankylosing spondylitis	0.000132	0.00201	CcSEcCtD
Cyclobenzaprine—Hypertension—Prednisone—ankylosing spondylitis	0.000131	0.002	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00013	0.00198	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00013	0.00198	CcSEcCtD
Cyclobenzaprine—Myalgia—Prednisone—ankylosing spondylitis	0.00013	0.00197	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00013	0.00197	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000129	0.00197	CcSEcCtD
Cyclobenzaprine—Anxiety—Prednisone—ankylosing spondylitis	0.000129	0.00196	CcSEcCtD
Cyclobenzaprine—Alopecia—Methotrexate—ankylosing spondylitis	0.000129	0.00196	CcSEcCtD
Cyclobenzaprine—Insomnia—Dexamethasone—ankylosing spondylitis	0.000129	0.00196	CcSEcCtD
Cyclobenzaprine—Insomnia—Betamethasone—ankylosing spondylitis	0.000129	0.00196	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000128	0.00195	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000128	0.00195	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000128	0.00195	CcSEcCtD
Cyclobenzaprine—Discomfort—Prednisone—ankylosing spondylitis	0.000128	0.00195	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000126	0.00192	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000126	0.00191	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000126	0.00191	CcSEcCtD
Cyclobenzaprine—Urticaria—Triamcinolone—ankylosing spondylitis	0.000125	0.0019	CcSEcCtD
Cyclobenzaprine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000125	0.0019	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000125	0.00189	CcSEcCtD
Cyclobenzaprine—Oedema—Prednisone—ankylosing spondylitis	0.000124	0.00189	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000124	0.00189	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000124	0.00189	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000124	0.00189	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000124	0.00189	CcSEcCtD
Cyclobenzaprine—Fatigue—Betamethasone—ankylosing spondylitis	0.000123	0.00187	CcSEcCtD
Cyclobenzaprine—Fatigue—Dexamethasone—ankylosing spondylitis	0.000123	0.00187	CcSEcCtD
Cyclobenzaprine—Shock—Prednisone—ankylosing spondylitis	0.000122	0.00186	CcSEcCtD
Cyclobenzaprine—Tachycardia—Prednisone—ankylosing spondylitis	0.000121	0.00184	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00012	0.00183	CcSEcCtD
Cyclobenzaprine—Vision blurred—Methotrexate—ankylosing spondylitis	0.00012	0.00182	CcSEcCtD
Cyclobenzaprine—Anorexia—Prednisone—ankylosing spondylitis	0.000118	0.0018	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000118	0.00179	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000118	0.00179	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000118	0.00179	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000117	0.00177	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000117	0.00177	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000116	0.00176	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000116	0.00176	CcSEcCtD
Cyclobenzaprine—Malaise—Methotrexate—ankylosing spondylitis	0.000115	0.00174	CcSEcCtD
Cyclobenzaprine—Vertigo—Methotrexate—ankylosing spondylitis	0.000114	0.00174	CcSEcCtD
Cyclobenzaprine—Leukopenia—Methotrexate—ankylosing spondylitis	0.000114	0.00173	CcSEcCtD
Cyclobenzaprine—Urticaria—Dexamethasone—ankylosing spondylitis	0.000113	0.00172	CcSEcCtD
Cyclobenzaprine—Urticaria—Betamethasone—ankylosing spondylitis	0.000113	0.00172	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000113	0.00172	CcSEcCtD
Cyclobenzaprine—Dizziness—Prednisolone—ankylosing spondylitis	0.000113	0.00172	CcSEcCtD
Cyclobenzaprine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000113	0.00172	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000113	0.00171	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000113	0.00171	CcSEcCtD
Cyclobenzaprine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000113	0.00171	CcSEcCtD
Cyclobenzaprine—Insomnia—Prednisone—ankylosing spondylitis	0.000112	0.00171	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Prednisone—ankylosing spondylitis	0.000112	0.0017	CcSEcCtD
Cyclobenzaprine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000111	0.00169	CcSEcCtD
Cyclobenzaprine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000111	0.00169	CcSEcCtD
Cyclobenzaprine—Convulsion—Methotrexate—ankylosing spondylitis	0.00011	0.00168	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Prednisone—ankylosing spondylitis	0.000109	0.00166	CcSEcCtD
Cyclobenzaprine—Chest pain—Methotrexate—ankylosing spondylitis	0.000108	0.00165	CcSEcCtD
Cyclobenzaprine—Myalgia—Methotrexate—ankylosing spondylitis	0.000108	0.00165	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Prednisone—ankylosing spondylitis	0.000108	0.00164	CcSEcCtD
Cyclobenzaprine—Rash—Prednisolone—ankylosing spondylitis	0.000108	0.00164	CcSEcCtD
Cyclobenzaprine—Dermatitis—Prednisolone—ankylosing spondylitis	0.000108	0.00164	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000107	0.00163	CcSEcCtD
Cyclobenzaprine—Fatigue—Prednisone—ankylosing spondylitis	0.000107	0.00163	CcSEcCtD
Cyclobenzaprine—Headache—Prednisolone—ankylosing spondylitis	0.000107	0.00163	CcSEcCtD
Cyclobenzaprine—Discomfort—Methotrexate—ankylosing spondylitis	0.000107	0.00163	CcSEcCtD
Cyclobenzaprine—Constipation—Prednisone—ankylosing spondylitis	0.000106	0.00162	CcSEcCtD
Cyclobenzaprine—Confusional state—Methotrexate—ankylosing spondylitis	0.000105	0.00159	CcSEcCtD
Cyclobenzaprine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000104	0.00158	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000104	0.00158	CcSEcCtD
Cyclobenzaprine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000104	0.00158	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000102	0.00156	CcSEcCtD
Cyclobenzaprine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000102	0.00156	CcSEcCtD
Cyclobenzaprine—Asthenia—Betamethasone—ankylosing spondylitis	0.000102	0.00156	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000102	0.00155	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000102	0.00154	CcSEcCtD
Cyclobenzaprine—Nausea—Prednisolone—ankylosing spondylitis	0.000102	0.00154	CcSEcCtD
Cyclobenzaprine—Pruritus—Dexamethasone—ankylosing spondylitis	0.000101	0.00153	CcSEcCtD
Cyclobenzaprine—Pruritus—Betamethasone—ankylosing spondylitis	0.000101	0.00153	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.0001	0.00153	CcSEcCtD
Cyclobenzaprine—Vomiting—Triamcinolone—ankylosing spondylitis	0.0001	0.00152	CcSEcCtD
Cyclobenzaprine—Vomiting—Methylprednisolone—ankylosing spondylitis	9.98e-05	0.00152	CcSEcCtD
Cyclobenzaprine—Rash—Triamcinolone—ankylosing spondylitis	9.92e-05	0.00151	CcSEcCtD
Cyclobenzaprine—Dermatitis—Triamcinolone—ankylosing spondylitis	9.91e-05	0.00151	CcSEcCtD
Cyclobenzaprine—Anorexia—Methotrexate—ankylosing spondylitis	9.9e-05	0.0015	CcSEcCtD
Cyclobenzaprine—Rash—Methylprednisolone—ankylosing spondylitis	9.9e-05	0.0015	CcSEcCtD
Cyclobenzaprine—Dermatitis—Methylprednisolone—ankylosing spondylitis	9.89e-05	0.0015	CcSEcCtD
Cyclobenzaprine—Urticaria—Prednisone—ankylosing spondylitis	9.87e-05	0.0015	CcSEcCtD
Cyclobenzaprine—Headache—Triamcinolone—ankylosing spondylitis	9.85e-05	0.0015	CcSEcCtD
Cyclobenzaprine—Headache—Methylprednisolone—ankylosing spondylitis	9.83e-05	0.00149	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Prednisone—ankylosing spondylitis	9.83e-05	0.00149	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Dexamethasone—ankylosing spondylitis	9.77e-05	0.00148	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Betamethasone—ankylosing spondylitis	9.77e-05	0.00148	CcSEcCtD
Cyclobenzaprine—Hypotension—Methotrexate—ankylosing spondylitis	9.71e-05	0.00148	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	9.46e-05	0.00144	CcSEcCtD
Cyclobenzaprine—Dizziness—Dexamethasone—ankylosing spondylitis	9.44e-05	0.00143	CcSEcCtD
Cyclobenzaprine—Dizziness—Betamethasone—ankylosing spondylitis	9.44e-05	0.00143	CcSEcCtD
Cyclobenzaprine—Insomnia—Methotrexate—ankylosing spondylitis	9.4e-05	0.00143	CcSEcCtD
Cyclobenzaprine—Nausea—Triamcinolone—ankylosing spondylitis	9.34e-05	0.00142	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Methotrexate—ankylosing spondylitis	9.33e-05	0.00142	CcSEcCtD
Cyclobenzaprine—Nausea—Methylprednisolone—ankylosing spondylitis	9.32e-05	0.00142	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Methotrexate—ankylosing spondylitis	9.26e-05	0.00141	CcSEcCtD
Cyclobenzaprine—Somnolence—Methotrexate—ankylosing spondylitis	9.23e-05	0.0014	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Prednisone—ankylosing spondylitis	9.16e-05	0.00139	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Methotrexate—ankylosing spondylitis	9.14e-05	0.00139	CcSEcCtD
Cyclobenzaprine—Vomiting—Dexamethasone—ankylosing spondylitis	9.07e-05	0.00138	CcSEcCtD
Cyclobenzaprine—Vomiting—Betamethasone—ankylosing spondylitis	9.07e-05	0.00138	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Methotrexate—ankylosing spondylitis	9.03e-05	0.00137	CcSEcCtD
Cyclobenzaprine—Rash—Dexamethasone—ankylosing spondylitis	9e-05	0.00137	CcSEcCtD
Cyclobenzaprine—Rash—Betamethasone—ankylosing spondylitis	9e-05	0.00137	CcSEcCtD
Cyclobenzaprine—Dermatitis—Betamethasone—ankylosing spondylitis	8.99e-05	0.00137	CcSEcCtD
Cyclobenzaprine—Dermatitis—Dexamethasone—ankylosing spondylitis	8.99e-05	0.00137	CcSEcCtD
Cyclobenzaprine—Fatigue—Methotrexate—ankylosing spondylitis	8.96e-05	0.00136	CcSEcCtD
Cyclobenzaprine—Headache—Betamethasone—ankylosing spondylitis	8.94e-05	0.00136	CcSEcCtD
Cyclobenzaprine—Headache—Dexamethasone—ankylosing spondylitis	8.94e-05	0.00136	CcSEcCtD
Cyclobenzaprine—Asthenia—Prednisone—ankylosing spondylitis	8.92e-05	0.00136	CcSEcCtD
Cyclobenzaprine—Pruritus—Prednisone—ankylosing spondylitis	8.79e-05	0.00134	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Methotrexate—ankylosing spondylitis	8.56e-05	0.0013	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Prednisone—ankylosing spondylitis	8.5e-05	0.00129	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	8.49e-05	0.00129	CcSEcCtD
Cyclobenzaprine—Nausea—Dexamethasone—ankylosing spondylitis	8.48e-05	0.00129	CcSEcCtD
Cyclobenzaprine—Nausea—Betamethasone—ankylosing spondylitis	8.48e-05	0.00129	CcSEcCtD
Cyclobenzaprine—Urticaria—Methotrexate—ankylosing spondylitis	8.25e-05	0.00125	CcSEcCtD
Cyclobenzaprine—Dizziness—Prednisone—ankylosing spondylitis	8.22e-05	0.00125	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Methotrexate—ankylosing spondylitis	8.21e-05	0.00125	CcSEcCtD
Cyclobenzaprine—Vomiting—Prednisone—ankylosing spondylitis	7.9e-05	0.0012	CcSEcCtD
Cyclobenzaprine—Rash—Prednisone—ankylosing spondylitis	7.84e-05	0.00119	CcSEcCtD
Cyclobenzaprine—Dermatitis—Prednisone—ankylosing spondylitis	7.83e-05	0.00119	CcSEcCtD
Cyclobenzaprine—Headache—Prednisone—ankylosing spondylitis	7.79e-05	0.00118	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Methotrexate—ankylosing spondylitis	7.65e-05	0.00116	CcSEcCtD
Cyclobenzaprine—Asthenia—Methotrexate—ankylosing spondylitis	7.45e-05	0.00113	CcSEcCtD
Cyclobenzaprine—Nausea—Prednisone—ankylosing spondylitis	7.38e-05	0.00112	CcSEcCtD
Cyclobenzaprine—Pruritus—Methotrexate—ankylosing spondylitis	7.35e-05	0.00112	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Methotrexate—ankylosing spondylitis	7.11e-05	0.00108	CcSEcCtD
Cyclobenzaprine—Dizziness—Methotrexate—ankylosing spondylitis	6.87e-05	0.00104	CcSEcCtD
Cyclobenzaprine—Vomiting—Methotrexate—ankylosing spondylitis	6.6e-05	0.001	CcSEcCtD
Cyclobenzaprine—Rash—Methotrexate—ankylosing spondylitis	6.55e-05	0.000995	CcSEcCtD
Cyclobenzaprine—Dermatitis—Methotrexate—ankylosing spondylitis	6.54e-05	0.000995	CcSEcCtD
Cyclobenzaprine—Headache—Methotrexate—ankylosing spondylitis	6.51e-05	0.000989	CcSEcCtD
Cyclobenzaprine—Nausea—Methotrexate—ankylosing spondylitis	6.17e-05	0.000938	CcSEcCtD
